Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
Saved in:
Main Authors: | Magnusson Bo (Author), Horne AnnaCarin (Author), Henter Jan-Inge (Author), Hagelberg Stefan (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2011-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic administration of etoposide coincides with reduced systemic HMGB1 levels in macrophage activation syndrome
by: Karin Palmblad, et al.
Published: (2021) -
Case Report: Successful avoidance of etoposide for primary hemophagocytic lymphohistiocytosis-induced multiple organ dysfunction syndrome using emapalumab
by: Timothy J. Hahn, et al.
Published: (2024) -
HEMOPHAGOCYTAL LYMPHOHISTIOCYTOSIS
by: M.A. Maschan, et al.
Published: (2009) -
HEMOPHAGOCYTAL LYMPHOHISTIOCYTOSIS
by: M.A. Maschan, et al.
Published: (2009) -
Hemophagocytic lymphohistiocytosis presenting as acute coronary syndrome
by: Gabriel Melki, et al.
Published: (2021)